Results 231 to 240 of about 37,318 (280)

Intraocular Lymphoma: A Review. [PDF]

open access: yesJ Ophthalmic Vis Res
Karimi S, Daneshvar K.
europepmc   +1 more source

Survival Outcomes and Complications Among Canadian Children With Retinoblastoma: A Population‐Based Report From CYP‐C

open access: yesPediatric Blood &Cancer, Volume 73, Issue 7, July 2026.
ABSTRACT Purpose Retinoblastoma (RB) is the most common pediatric ocular cancer, yet population‐based data on survival and risk factors remain limited. This study aimed to describe survival in a large national RB cohort and identify predictors of death and complications.
Samuel Sassine   +14 more
wiley   +1 more source

One year follow up in siblings with TREX1-associated retinal vasculopathy with cerebral leukodystrophy. [PDF]

open access: yesAm J Ophthalmol Case Rep
Mylonas G   +10 more
europepmc   +1 more source

Intravitreal GD2‐Specific Chimeric Antigen Receptor T‐Cell Therapy for Refractory Retinoblastoma

open access: yesPediatric Blood &Cancer, Volume 73, Issue 7, July 2026.
ABSTRACT Effective treatments for advanced, treatment‐resistant retinoblastoma (RB) remain limited. GD2‐specific chimeric antigen receptor (CAR) T cells show potent antitumor activity with minimal toxicity but have not previously been evaluated in RB.
Subongkoch Subhadhirasakul   +13 more
wiley   +1 more source

Very rapid response to belzutifan of VHL-related intracranial and retinal hemangioblastomas. [PDF]

open access: yesAm J Ophthalmol Case Rep
Pagliara A   +13 more
europepmc   +1 more source

Differentiating the Clinical and Variant Spectrum of Hardikar Syndrome From Other MED12 ‐Related Developmental Disorders

open access: yesAmerican Journal of Medical Genetics Part A, Volume 200, Issue 7, Page 1619-1650, July 2026.
ABSTRACT The rare X‐linked female‐restricted Hardikar syndrome (HDKR, OMIM # 301068) is characterized by multiple congenital anomalies including orofacial clefts, gastrointestinal, genitourinary, and cardiac anomalies, but cognitive and neurobehavioral development is rarely impaired.
Tinne Warmoeskerken   +4 more
wiley   +1 more source

BIRC5 drives cell-cycle dysregulation and represents a novel molecular target in retinoblastoma. [PDF]

open access: yesFront Oncol
Chen Y   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy